XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses        
Research and development $ 615 $ 1,509 $ 3,095 $ 6,795
General and administrative 3,731 1,411 6,730 5,089
Restructuring expense 1,802   2,292  
Total operating expenses 6,148 2,920 12,117 11,884
Loss from operations (6,148) (2,920) (12,117) (11,884)
Other income, net 4 27 39 17
Warrant inducement expense     (4,829)  
Net loss and comprehensive loss $ (6,144) $ (2,893) $ (16,907) $ (11,867)
Net loss per share, basic and diluted $ (5.51) $ (4.01) $ (16.81) $ (18.74)
Weighted-average common shares outstanding, basic and diluted 1,114,133 720,829 1,006,008 633,187